SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-003163
Filing Date
2019-01-28
Accepted
2019-01-28 16:35:44
Documents
6
Period of Report
2019-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv511695_8k.htm 8-K 33637
2 OFFER LETTER AGREEMENT tv511695_ex10-1.htm EX-10.1 12912
3 PRESS RELEASE tv511695_ex99-1.htm EX-99.1 10054
4 GRAPHIC tv511695_ex10-1img1.jpg GRAPHIC 11988
5 GRAPHIC tv511695_ex10-1img2.jpg GRAPHIC 10096
6 GRAPHIC tv511695_ex99-1img1.jpg GRAPHIC 4887
  Complete submission text file 0001144204-19-003163.txt   95448
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 19545907
SIC: 2834 Pharmaceutical Preparations